USD 184.85 billion
Small Molecule API Market Size, Share, Growth Analysis, By Type (Synthetic, Biotech), By Manufacturer (In-house, Outsourced), By Application (Cardiology, Oncology), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2356 |
Region:
Global |
Published Date: November, 2024
Pages:
172
|Tables:
95
|Figures:
67
Small Molecule API Market Insights
Small Molecule API Market size was valued at USD 194.9 Billion in 2023 and is poised to grow from USD 205.5 Billion in 2024 to USD 313.96 Billion by 2032, growing at a CAGR of 5.44% during the forecast period (2025-2032).
Surging incidence of chronic diseases around the world and growing investments in drug discovery and development are projected to bolster the demand for small molecule API (active pharmaceutical ingredient) over the coming years. Surging costs of branded drugs is bolstering the demand for generic drugs, which in turn is estimated to favor small molecule API market growth going forward. Advancements in API synthesis technologies and rising investments in small molecule research and development are also expected to create new opportunities for small molecule API providers in the long run. Rising demand for affordable oncology drugs is also estimated to promote market growth on a global level. However, complex manufacturing, high costs of small molecule API manufacturing, and imposition of stringent regulatory mandates are estimated to slow down the demand for small molecule API in the future. Adoption of sustainable and continuous manufacturing approaches could create new business scope for small molecule API companies in the long run.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Cardiology
Fastest Growth
Synthetic
Growth Rate
5.44%
Global Small Molecule API Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Small Molecule API Market Segmental Analysis
Global Small Molecule API Market is segmented on the type, manufacturer, application, and region. By type, the market is segmented into Synthetic and Biotech. By manufacturer, the market is segmented into In-house and Outsourced. By application, the market is segmented into Cardiology, Oncology, CNS and Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Type
Synthetic small molecule API products are projected to account for a dominant share of the global market. Growing demand for synthetic drugs and rising use of synthetic small molecules in the manufacturing of the same are predicted to help the high market share of this segment in the long run. Easy production and their high efficacy in different pharmaceutical products are other factors that will help the dominance of this segment going forward.
On the other hand, the demand for biotech-based small molecule APIs is projected to rise at a notable pace across the forecast period. Advancements in biotechnology and rising popularity of biotech-based drugs and products are anticipated to help market growth via this segment in the future. Surging demand for targeted therapies owing to rising awareness regarding their benefits will also benefit the demand for biotech-based small molecule APIs in the long run.
Analysis by Manufacturing
In-house manufacturing of small molecule APIs is projected to account for a prominent chunk of the global market share. Large pharmaceutical companies are projected to contribute to the dominance of this segment as they focus on eleminating their dependence on suppliers and supply chain disruptions. Growing investments in development of new in-house small molecule API manufacturing facilities by different companies around the world will also create new opportunities for market players in this segment.
On the other hand, the demand for outsourced small molecule API manufacturing is forecasted to increase at a notable pace across the study period. Increasing involvement of new companies in drug development and manufacturing is a key factor boosting the demand for outsourced manufacturing of small molecule API. Growing emphasis on resource utilization, rising popularity of outsourcing in healthcare, and increasing number of contract research organizations around the world are also predicted to create new opportunities for small molecule API providers in long run.
Global Small Molecule API Market By Manufacturing
To get detailed analysis on other segments, Request For Free Sample Report
Small Molecule API Market Regional Insights
North America is slated to account for a dominant share of the global small molecule API market. Presence of key pharmaceutical companies, rising costs of healthcare, and growing demand for generic drugs are projected to key factors helping small molecule API demand outlook in this region. The United States is projected to spearhead small molecule API market growth in North America followed by Canada. High investments in medical R&D and supportive government initiatives for the same are also expected to create new opportunities for small molecule API providers operating in North America.
Growing investments in healthcare infrastructure development and rising demand for drugs to treat chronic diseases are projected to be prime factors allowing Asia Pacific to become the most opportune market. Presence of multiple contract research organizations in this region and rising demand for generic drugs are also projected to create new business scope for small molecule API companies operating in this region. India, China, and Japan are estimated to spearhead revenue generation for small molecule API providers looking to make a mark in this region.
Global Small Molecule API Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Small Molecule API Market Dynamics
Drivers
High Incidence of Chronic Diseases
- Poor lifestyle choices have led to an increased prevalence of multiple chronic disorders around the world and this is boosting the demand for pharmaceuticals as well. Increasing demand for pharmaceuticals is projected to favor small molecule API market growth as well.
Growing Sales of Generic Drugs
- Rising costs of healthcare around the world are pushing people to opt for generic drugs instead of branded ones, which are generally the costlier alternative. Growing emphasis on healthcare accessibility will also promote sales of generic drugs and thereby boost small molecule API demand as well.
Restraints
High Costs of Manufacturing
- Manufacturing small molecule API is quite an expensive task as it requires specialized equipment setups and skilled professionals to handle the same. Use of expensive raw materials also contributes to the high costs of small molecule API manufacturing and impedes market development potential.
Popularity of Biologics
- Biologics are gaining massive traction around the world owing to their better efficacy and affordable nature as compared to small molecule drugs. This increase in preference and popularity could slow down small molecule API demand outlook in the future.
Request Free Customization of this report to help us to meet your business objectives.
Small Molecule API Market Competitive Landscape
Reducing the costs and complexity of small molecule API manufacturing should be the prime focus of market players. Collaborations and mergers will also play a vital role in helping small molecule API companies maximize their business scope in the long run. Investing in research and development of advanced small molecule API will also be an unmissable strategy for all small molecule API suppliers going forward.
Top Player’s Company Profiles
- Johnson Matthey (UK)
- Pfizer Inc. (US)
- Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd. (China)
- Sanofi S.A. (France)
- Novartis AG (Switzerland)
- Bristol-Myers Squibb (US)
- Boehringer Ingelheim GmbH (Germany)
- GlaxoSmithKline PLC (UK)
- GILEAD Sciences Inc. (US)
- Albany Molecular Research Inc. (US)
- AstraZeneca (UK)
- Merck & Co. Inc. (US)
- BASF SE (Germany)
- Teva Pharmaceuticals (Israel)
- Hoffmann-La Roche Ltd. (Switzerland)
- Albemarle Corporation (US)
- AbbVie (US)
- Aurobindo Pharma (India)
- Cambrex Corporation (US)
- Dr. Reddy’s Laboratories Ltd. (India)
- Lonza (Switzerland)
- Merck KGaA (Germany)
- Siegfried Holding AG (Switzerland)
- Sun Pharmaceutical Industries Ltd. (India)
Recent Developments
- Lonza, a leading Swiss multinational manufacturer for biotechnology and pharmaceutical industries announced the launch of its new AI service to fast track the development of small molecules in April 2024. This was aimed at streamlining the complexity of small molecule API development process.
- Veranova, a leading provider of APIs revealed its plans to invest USD 30 million to expand its manufacturing capabilities in July 2024. The investment is intended to be used for the Devens, Massachusetts facility as demand for small molecules increases in the United States.
- WuXi AppTec, a renowned name in the healthcare manufacturing space announced the launch of its new API manufacturing facility while it increased its Peptide manufacturing capacity in Taixing, China in January 2024.
Small Molecule API Key Market Trends
- Rise of Personalized Medicine: Small molecule API providers can focus on optimizing their business models to suit the needs of personalized medicine, which is gaining popularity on a global level. Developing small molecule API for niche markets and individuals will offer good returns for all market players in the future.
- Use of Sustainable Manufacturing Practices: Small molecule API companies should focus on investing in the use of sustainable manufacturing technologies and techniques to enhance their business scope going forward. Making sure small molecule API manufacturing complies with modern sustainability mandates will further boost revenue generation potential for market players in the long run.
Small Molecule API Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, rising incidence of chronic diseases and growing demand for pharmaceuticals and drugs are predicted to create new opportunities for small molecule API companies. However, high costs of manufacturing and rising popularity of biologics are slated to slow down small molecule API demand outlook. North America is estimated to spearhead the sales of small molecule APIs across the study period owing to rising demand for generic drugs. Use of sustainable manufacturing practices will help small molecule API companies maximize their business scope in the long run.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 194.9 Billion |
| Market size value in 2032 | USD 313.96 Billion |
| Growth Rate | 5.44% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Small Molecule API Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Small Molecule API Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Small Molecule API Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Small Molecule API Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Small Molecule API Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Small Molecule API Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
